Effect of Charge Ratio on lipoplex-mediated Gene Delivery and Liver Toxicity

References

• Xu L Anchordoquy T . Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J. Pharm. Sci.100 (1), 38–52 (2011).
   PubMed Web of Science ®Google Scholar
• Thi EP Mire CE Lee AC et al. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature521 (7552), 362–365 (2015).
   PubMed Web of Science ®Google Scholar
• Nchinda G Zschornig O Uberla K . Increased non-viral gene transfer levels in mice by concentration of cationic lipid DNA complexes formed under optimized conditions. J. Gene Med.5 (8), 712–722 (2003).
   PubMed Web of Science ®Google Scholar
• Ross PC Hui SW . Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther.6 (4), 651–659 (1999).
   PubMed Web of Science ®Google Scholar
• Zhang Y Garzon-Rodriguez W Manning MC Anchordoquy TJ . The use of fluorescence resonance energy transfer to monitor dynamic changes of lipid-DNA interactions during lipoplex formation. Biochim. Biophys. Acta1614 (2), 182–192 (2003).
   PubMed Web of Science ®Google Scholar
• Zuidam NJ Hirsch-Lerner D Margulies S Barenholz Y . Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency. Biochim. Biophys. Acta1419 (2), 207–220 (1999).
   PubMed Web of Science ®Google Scholar
• Betker JL Anchordoquy TJ . Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro. Mol. Pharm.12 (1), 264–273 (2015).
   PubMedGoogle Scholar
• Zhang Y Anchordoquy TJ . The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochim. Biophys. Acta1663 (1–2), 143–157 (2004).
   PubMed Web of Science ®Google Scholar
• Betker JL Gomez J Anchordoquy TJ . The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency. J. Control. Release171 (3), 261–268 (2013).
   PubMed Web of Science ®Google Scholar
• Xu L Wempe MF Anchordoquy TJ . The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro. Ther. Deliv.2 (4), 451–460 (2011).
   PubMedGoogle Scholar
• Gao X Huang L . Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry35 (3), 1027–1036 (1996).
   PubMed Web of Science ®Google Scholar
• Hofland HE Shephard L Sullivan SM . Formation of stable cationic lipid/DNA complexes for gene transfer. Proc. Natl Acad. Sci. USA93 (14), 7305–7309 (1996).
   PubMed Web of Science ®Google Scholar
• Abrams MT Koser ML Seitzer J et al. Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment. Mol. Ther.18 (1), 171–180 (2010).
   PubMed Web of Science ®Google Scholar
• Betker JL Kullberg M Gomez J Anchordoquy TJ . Cholesterol domains enhance transfection. Ther. Deliv.4 (4), 453–462 (2013).
   PubMedGoogle Scholar
• Xu L Betker J Yin H Anchordoquy TJ . Ligands located within a cholesterol domain enhance gene delivery to the target tissue. J. Control. Release160 (1), 57–63 (2012).
   PubMed Web of Science ®Google Scholar
• Watcharanurak K Nishikawa M Takahashi Y Takakura Y . Controlling the kinetics of interferon transgene expression for improved gene therapy. J. Drug Target.20 (9), 764–769 (2012).
   PubMed Web of Science ®Google Scholar
• Xu L Anchordoquy TJ . Cholesterol domains in cationic lipid/DNA complexes improve transfection. Biochim. Biophys. Acta1778 (10), 2177–2181 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang Y Bradshaw-Pierce EL Delille A Gustafson DL Anchordoquy TJ . In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J. Pharm. Sci.97 (1), 237–250 (2008).
   PubMed Web of Science ®Google Scholar
• Moghimi SM Hamad I Andresen TL Jorgensen K Szebeni J . Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. FASEB J.20 (14), 2591–2593 (2006).
   PubMed Web of Science ®Google Scholar
• Moghimi SM Farhangrazi ZS . Just so stories: the random acts of anti-cancer nanomedicine performance. Nanomedicine10 (8), 1661–1666 (2014).
   PubMed Web of Science ®Google Scholar
• Sabnani MK Rajan R Rowland B et al. Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses. Nanomedicine11 (2), 259–262 (2015).
   PubMed Web of Science ®Google Scholar
• Matsumura Y Maeda H . A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res.46 (12 Pt 1), 6387–6392 (1986).
   PubMed Web of Science ®Google Scholar
• Lammers T Kiessling F Hennink WE Storm G . Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J. Control. Release161 (2), 175–187 (2012).
   PubMed Web of Science ®Google Scholar
• Perrault SD Walkey C Jennings T Fischer HC Chan WC . Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett.9 (5), 1909–1915 (2009).
   PubMed Web of Science ®Google Scholar
• Knop K Hoogenboom R Fischer D Schubert US . Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl.49 (36), 6288–6308 (2010).
   PubMed Web of Science ®Google Scholar
• Moghimi SM Hunter AC Andresen TL . Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol.52, 481–503 (2012).
   PubMed Web of Science ®Google Scholar
• Moghimi SM Szebeni J . Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res.42 (6), 463–478 (2003).
   PubMed Web of Science ®Google Scholar
• Chastagner P Sudour H Mriouah J Barberi-Heyob M Bernier-Chastagner V Pinel S . Preclinical studies of pegylated- and non-pegylated liposomal forms of doxorubicin as radiosensitizer on orthotopic high-grade glioma xenografts. Pharm. Res.32 (1), 158–166 (2015).
   PubMed Web of Science ®Google Scholar
• Saadati R Dadashzadeh S Abbasian Z Soleimanjahi H . Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug. Pharm. Res.30 (4), 985–995 (2013).
   PubMed Web of Science ®Google Scholar
• Semple SC Harasym TO Clow KA Ansell SM Klimuk SK Hope MJ . Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J. Pharmacol. Exp. Ther.312 (3), 1020–1026 (2005).
   PubMed Web of Science ®Google Scholar
• Molino NM Bilotkach K Fraser DA Ren DM Wang SW . Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules. Biomacromolecules13 (4), 974–981 (2012).
   PubMed Web of Science ®Google Scholar
• Verhoef JJF Anchordoquy TJ . Questioning the use of PEGylation for drug delivery. Drug Deliv. Transl. Res.3 (6), 499–503 (2013).
   PubMed Web of Science ®Google Scholar
• Kullberg M Mccarthy R Anchordoquy TJ . Systemic tumor-specific gene delivery. J. Control. Release172 (3), 730–736 (2013).
   PubMed Web of Science ®Google Scholar